The global market for Nimodipine was valued at US$ 572 million in the year 2024 and is projected to reach a revised size of US$ 846 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Nimodipine Market

Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure.

North American market for Nimodipine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nimodipine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nimodipine include Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Yangtze River Pharmaceutical, Cisen Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Shandong Xinhua Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nimodipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nimodipine.

The Nimodipine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nimodipine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nimodipine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nimodipine Market Report

Report Metric	Details
Report Name	Nimodipine Market
Accounted market size in year	US$ 572 million
Forecasted market size in 2031	US$ 846 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Capsule Solution Tablets
Segment by Application	Hospital Pharmacy Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Yangtze River Pharmaceutical, Cisen Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Shandong Xinhua Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nimodipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nimodipine Market growing?

Ans: The Nimodipine Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Nimodipine Market size in 2031?

Ans: The Nimodipine Market size in 2031 will be US$ 846 million.

Who are the main players in the Nimodipine Market report?

Ans: The main players in the Nimodipine Market are Bayer, Azurity, Avet Pharmaceuticals Inc., Bionpharma, Yangtze River Pharmaceutical, Cisen Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Shandong Xinhua Pharmaceutical

What are the Application segmentation covered in the Nimodipine Market report?

Ans: The Applications covered in the Nimodipine Market report are Hospital, Pharmacy, Clinics, Others

What are the Type segmentation covered in the Nimodipine Market report?

Ans: The Types covered in the Nimodipine Market report are Capsule, Solution, Tablets

1 Nimodipine Market Overview

1.1 Product Definition

1.2 Nimodipine by Type

1.2.1 Global Nimodipine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Capsule

1.2.3 Solution

1.2.4 Tablets

1.3 Nimodipine by Application

1.3.1 Global Nimodipine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Clinics

1.3.5 Others

1.4 Global Nimodipine Market Size Estimates and Forecasts

1.4.1 Global Nimodipine Revenue 2020-2031

1.4.2 Global Nimodipine Sales 2020-2031

1.4.3 Global Nimodipine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Nimodipine Market Competition by Manufacturers

2.1 Global Nimodipine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nimodipine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nimodipine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nimodipine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nimodipine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nimodipine, Product Type & Application

2.7 Global Key Manufacturers of Nimodipine, Date of Enter into This Industry

2.8 Global Nimodipine Market Competitive Situation and Trends

2.8.1 Global Nimodipine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nimodipine Players Market Share by Revenue

2.8.3 Global Nimodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nimodipine Market Scenario by Region

3.1 Global Nimodipine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nimodipine Sales by Region: 2020-2031

3.2.1 Global Nimodipine Sales by Region: 2020-2025

3.2.2 Global Nimodipine Sales by Region: 2026-2031

3.3 Global Nimodipine Revenue by Region: 2020-2031

3.3.1 Global Nimodipine Revenue by Region: 2020-2025

3.3.2 Global Nimodipine Revenue by Region: 2026-2031

3.4 North America Nimodipine Market Facts & Figures by Country

3.4.1 North America Nimodipine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nimodipine Sales by Country (2020-2031)

3.4.3 North America Nimodipine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nimodipine Market Facts & Figures by Country

3.5.1 Europe Nimodipine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nimodipine Sales by Country (2020-2031)

3.5.3 Europe Nimodipine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nimodipine Market Facts & Figures by Region

3.6.1 Asia Pacific Nimodipine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nimodipine Sales by Region (2020-2031)

3.6.3 Asia Pacific Nimodipine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Nimodipine Market Facts & Figures by Country

3.7.1 Latin America Nimodipine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nimodipine Sales by Country (2020-2031)

3.7.3 Latin America Nimodipine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nimodipine Market Facts & Figures by Country

3.8.1 Middle East and Africa Nimodipine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nimodipine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nimodipine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Nimodipine Sales by Type (2020-2031)

4.1.1 Global Nimodipine Sales by Type (2020-2025)

4.1.2 Global Nimodipine Sales by Type (2026-2031)

4.1.3 Global Nimodipine Sales Market Share by Type (2020-2031)

4.2 Global Nimodipine Revenue by Type (2020-2031)

4.2.1 Global Nimodipine Revenue by Type (2020-2025)

4.2.2 Global Nimodipine Revenue by Type (2026-2031)

4.2.3 Global Nimodipine Revenue Market Share by Type (2020-2031)

4.3 Global Nimodipine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nimodipine Sales by Application (2020-2031)

5.1.1 Global Nimodipine Sales by Application (2020-2025)

5.1.2 Global Nimodipine Sales by Application (2026-2031)

5.1.3 Global Nimodipine Sales Market Share by Application (2020-2031)

5.2 Global Nimodipine Revenue by Application (2020-2031)

5.2.1 Global Nimodipine Revenue by Application (2020-2025)

5.2.2 Global Nimodipine Revenue by Application (2026-2031)

5.2.3 Global Nimodipine Revenue Market Share by Application (2020-2031)

5.3 Global Nimodipine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Company Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer Nimodipine Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Azurity

6.2.1 Azurity Company Information

6.2.2 Azurity Description and Business Overview

6.2.3 Azurity Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Azurity Nimodipine Product Portfolio

6.2.5 Azurity Recent Developments/Updates

6.3 Avet Pharmaceuticals Inc.

6.3.1 Avet Pharmaceuticals Inc. Company Information

6.3.2 Avet Pharmaceuticals Inc. Description and Business Overview

6.3.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Avet Pharmaceuticals Inc. Nimodipine Product Portfolio

6.3.5 Avet Pharmaceuticals Inc. Recent Developments/Updates

6.4 Bionpharma

6.4.1 Bionpharma Company Information

6.4.2 Bionpharma Description and Business Overview

6.4.3 Bionpharma Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bionpharma Nimodipine Product Portfolio

6.4.5 Bionpharma Recent Developments/Updates

6.5 Yangtze River Pharmaceutical

6.5.1 Yangtze River Pharmaceutical Company Information

6.5.2 Yangtze River Pharmaceutical Description and Business Overview

6.5.3 Yangtze River Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Yangtze River Pharmaceutical Nimodipine Product Portfolio

6.5.5 Yangtze River Pharmaceutical Recent Developments/Updates

6.6 Cisen Pharmaceutical

6.6.1 Cisen Pharmaceutical Company Information

6.6.2 Cisen Pharmaceutical Description and Business Overview

6.6.3 Cisen Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Cisen Pharmaceutical Nimodipine Product Portfolio

6.6.5 Cisen Pharmaceutical Recent Developments/Updates

6.7 Jiangsu Hengrui Pharmaceuticals

6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information

6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview

6.7.3 Jiangsu Hengrui Pharmaceuticals Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio

6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates

6.8 Sichuan Kelun Pharmaceutical

6.8.1 Sichuan Kelun Pharmaceutical Company Information

6.8.2 Sichuan Kelun Pharmaceutical Description and Business Overview

6.8.3 Sichuan Kelun Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio

6.8.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates

6.9 Hubei Jumpcan Pharmaceutical

6.9.1 Hubei Jumpcan Pharmaceutical Company Information

6.9.2 Hubei Jumpcan Pharmaceutical Description and Business Overview

6.9.3 Hubei Jumpcan Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio

6.9.5 Hubei Jumpcan Pharmaceutical Recent Developments/Updates

6.10 Shandong Xinhua Pharmaceutical

6.10.1 Shandong Xinhua Pharmaceutical Company Information

6.10.2 Shandong Xinhua Pharmaceutical Description and Business Overview

6.10.3 Shandong Xinhua Pharmaceutical Nimodipine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio

6.10.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nimodipine Industry Chain Analysis

7.2 Nimodipine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nimodipine Production Mode & Process Analysis

7.4 Nimodipine Sales and Marketing

7.4.1 Nimodipine Sales Channels

7.4.2 Nimodipine Distributors

7.5 Nimodipine Customer Analysis

8 Nimodipine Market Dynamics

8.1 Nimodipine Industry Trends

8.2 Nimodipine Market Drivers

8.3 Nimodipine Market Challenges

8.4 Nimodipine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bionpharma

Bayer

Avet Pharmaceuticals Inc.

Cisen Pharmaceutical

Azurity

Yangtze River Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Sichuan Kelun Pharmaceutical

Hubei Jumpcan Pharmaceutical

Shandong Xinhua Pharmaceutical

List of Tables

Table 1. Global Nimodipine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nimodipine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Nimodipine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Nimodipine Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Nimodipine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Nimodipine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Nimodipine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Nimodipine Average Price (USD/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Nimodipine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nimodipine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nimodipine, Product Type & Application

Table 12. Global Key Manufacturers of Nimodipine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nimodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nimodipine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nimodipine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nimodipine Sales by Region (2020-2025) & (MT)

Table 18. Global Nimodipine Sales Market Share by Region (2020-2025)

Table 19. Global Nimodipine Sales by Region (2026-2031) & (MT)

Table 20. Global Nimodipine Sales Market Share by Region (2026-2031)

Table 21. Global Nimodipine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Nimodipine Revenue Market Share by Region (2020-2025)

Table 23. Global Nimodipine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Nimodipine Revenue Market Share by Region (2026-2031)

Table 25. North America Nimodipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Nimodipine Sales by Country (2020-2025) & (MT)

Table 27. North America Nimodipine Sales by Country (2026-2031) & (MT)

Table 28. North America Nimodipine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Nimodipine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Nimodipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Nimodipine Sales by Country (2020-2025) & (MT)

Table 32. Europe Nimodipine Sales by Country (2026-2031) & (MT)

Table 33. Europe Nimodipine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Nimodipine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Nimodipine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Nimodipine Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Nimodipine Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Nimodipine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Nimodipine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nimodipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Nimodipine Sales by Country (2020-2025) & (MT)

Table 42. Latin America Nimodipine Sales by Country (2026-2031) & (MT)

Table 43. Latin America Nimodipine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nimodipine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Nimodipine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Nimodipine Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Nimodipine Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Nimodipine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Nimodipine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Nimodipine Sales (MT) by Type (2020-2025)

Table 51. Global Nimodipine Sales (MT) by Type (2026-2031)

Table 52. Global Nimodipine Sales Market Share by Type (2020-2025)

Table 53. Global Nimodipine Sales Market Share by Type (2026-2031)

Table 54. Global Nimodipine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Nimodipine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Nimodipine Revenue Market Share by Type (2020-2025)

Table 57. Global Nimodipine Revenue Market Share by Type (2026-2031)

Table 58. Global Nimodipine Price (USD/Kg) by Type (2020-2025)

Table 59. Global Nimodipine Price (USD/Kg) by Type (2026-2031)

Table 60. Global Nimodipine Sales (MT) by Application (2020-2025)

Table 61. Global Nimodipine Sales (MT) by Application (2026-2031)

Table 62. Global Nimodipine Sales Market Share by Application (2020-2025)

Table 63. Global Nimodipine Sales Market Share by Application (2026-2031)

Table 64. Global Nimodipine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Nimodipine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Nimodipine Revenue Market Share by Application (2020-2025)

Table 67. Global Nimodipine Revenue Market Share by Application (2026-2031)

Table 68. Global Nimodipine Price (USD/Kg) by Application (2020-2025)

Table 69. Global Nimodipine Price (USD/Kg) by Application (2026-2031)

Table 70. Bayer Company Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. Bayer Nimodipine Product

Table 74. Bayer Recent Developments/Updates

Table 75. Azurity Company Information

Table 76. Azurity Description and Business Overview

Table 77. Azurity Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Azurity Nimodipine Product

Table 79. Azurity Recent Developments/Updates

Table 80. Avet Pharmaceuticals Inc. Company Information

Table 81. Avet Pharmaceuticals Inc. Description and Business Overview

Table 82. Avet Pharmaceuticals Inc. Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Avet Pharmaceuticals Inc. Nimodipine Product

Table 84. Avet Pharmaceuticals Inc. Recent Developments/Updates

Table 85. Bionpharma Company Information

Table 86. Bionpharma Description and Business Overview

Table 87. Bionpharma Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Bionpharma Nimodipine Product

Table 89. Bionpharma Recent Developments/Updates

Table 90. Yangtze River Pharmaceutical Company Information

Table 91. Yangtze River Pharmaceutical Description and Business Overview

Table 92. Yangtze River Pharmaceutical Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Yangtze River Pharmaceutical Nimodipine Product

Table 94. Yangtze River Pharmaceutical Recent Developments/Updates

Table 95. Cisen Pharmaceutical Company Information

Table 96. Cisen Pharmaceutical Description and Business Overview

Table 97. Cisen Pharmaceutical Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Cisen Pharmaceutical Nimodipine Product

Table 99. Cisen Pharmaceutical Recent Developments/Updates

Table 100. Jiangsu Hengrui Pharmaceuticals Company Information

Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview

Table 102. Jiangsu Hengrui Pharmaceuticals Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. Jiangsu Hengrui Pharmaceuticals Nimodipine Product

Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates

Table 105. Sichuan Kelun Pharmaceutical Company Information

Table 106. Sichuan Kelun Pharmaceutical Description and Business Overview

Table 107. Sichuan Kelun Pharmaceutical Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Sichuan Kelun Pharmaceutical Nimodipine Product

Table 109. Sichuan Kelun Pharmaceutical Recent Developments/Updates

Table 110. Hubei Jumpcan Pharmaceutical Company Information

Table 111. Hubei Jumpcan Pharmaceutical Description and Business Overview

Table 112. Hubei Jumpcan Pharmaceutical Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Hubei Jumpcan Pharmaceutical Nimodipine Product

Table 114. Hubei Jumpcan Pharmaceutical Recent Developments/Updates

Table 115. Shandong Xinhua Pharmaceutical Company Information

Table 116. Shandong Xinhua Pharmaceutical Description and Business Overview

Table 117. Shandong Xinhua Pharmaceutical Nimodipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Shandong Xinhua Pharmaceutical Nimodipine Product

Table 119. Shandong Xinhua Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Nimodipine Distributors List

Table 123. Nimodipine Customers List

Table 124. Nimodipine Market Trends

Table 125. Nimodipine Market Drivers

Table 126. Nimodipine Market Challenges

Table 127. Nimodipine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nimodipine

Figure 2. Global Nimodipine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nimodipine Market Share by Type: 2024 & 2031

Figure 4. Capsule Product Picture

Figure 5. Solution Product Picture

Figure 6. Tablets Product Picture

Figure 7. Global Nimodipine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Nimodipine Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Clinics

Figure 12. Others

Figure 13. Global Nimodipine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Nimodipine Market Size (2020-2031) & (US$ Million)

Figure 15. Global Nimodipine Sales (2020-2031) & (MT)

Figure 16. Global Nimodipine Average Price (USD/Kg) & (2020-2031)

Figure 17. Nimodipine Report Years Considered

Figure 18. Nimodipine Sales Share by Manufacturers in 2024

Figure 19. Global Nimodipine Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Nimodipine Players: Market Share by Revenue in Nimodipine in 2024

Figure 21. Nimodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Nimodipine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Nimodipine Sales Market Share by Country (2020-2031)

Figure 24. North America Nimodipine Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Nimodipine Sales Market Share by Country (2020-2031)

Figure 28. Europe Nimodipine Revenue Market Share by Country (2020-2031)

Figure 29. Germany Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Nimodipine Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Nimodipine Revenue Market Share by Region (2020-2031)

Figure 36. China Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Nimodipine Sales Market Share by Country (2020-2031)

Figure 47. Latin America Nimodipine Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Nimodipine Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Nimodipine Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Nimodipine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Nimodipine by Type (2020-2031)

Figure 57. Global Revenue Market Share of Nimodipine by Type (2020-2031)

Figure 58. Global Nimodipine Price (USD/Kg) by Type (2020-2031)

Figure 59. Global Sales Market Share of Nimodipine by Application (2020-2031)

Figure 60. Global Revenue Market Share of Nimodipine by Application (2020-2031)

Figure 61. Global Nimodipine Price (USD/Kg) by Application (2020-2031)

Figure 62. Nimodipine Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Nimodipine Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-18D7023

Global Nimodipine Market Research Report 2025

FEATURED COMPANIES

Nimodipine Market Size

Nimodipine Market

Report Scope

Scope of Nimodipine Market Report

Core Chapters

FAQ for this report

How fast is Nimodipine Market growing?

What is the Nimodipine Market size in 2031?

Who are the main players in the Nimodipine Market report?

What are the Application segmentation covered in the Nimodipine Market report?

What are the Type segmentation covered in the Nimodipine Market report?

FEATURED COMPANIES

Epigenetics Market

Enterprise License, Electronic (PDF)